S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2 RANDOMIZED ROSEWOOD TRIAL. (23rd June 2022) - Zinzani, P. L.; Mayer, J.; Auer, R.; Bijou, F.; de Oliveira, A. C.; Flowers, C. R.; Merli, M.; Bouabdallah, K.; Ganly, P. S.; Song, Y.; Zhang, H.; Johnson, R.; et al.